Literature DB >> 26715436

Surgery has a key role for quality assurance of colorectal cancer screening programs: impact of the third level multidisciplinary team on lymph nodal staging.

Francesco Bianco1, Silvia De Franciscis2, Andrea Belli2, Maria Di Lena2, Antonio Avallone3, Maria Antonia Bianco4, Sabato Di Marzo5, Letizia Gigli6, Gianluca Rotondano4, Silvana Russo Spena6, Fabiana Tatangelo7, Alfonso Tempesta8, Giovanni Maria Romano2.   

Abstract

PURPOSE: From 2011 to 2013 in the area of the Naples 3 public health district (ASL-NA3), a colorectal cancer screening program (CCSP) was developed. In order to stress the need of quality assurance procedures for surgery and pathology, a third level oncologic pathway was added and set up at a referral colorectal cancer center (RC). Lymph nodal (LN) harvesting, as a process indicator, and nodal positivity were adopted for an interim analysis.
METHODS: The program was implemented by a series of audit meetings and a double type of multidisciplinary team (MDT): "horizontal" and "vertical." Three hundred and forty colorectal cancer (CRC) patients underwent surgery: 119 chose to be operated at the RC (Gr In), 65 were operated at 22 district hospitals (DH) (Gr Out), and 156 symptomatic not screened patients were operated at the RC (Gr Sym).
RESULTS: Statistical analysis revealed differences between Gr In and Gr Out colon groups both for LN harvesting (median of 26 and 11, respectively, P = 0.0001), and for nodal positivity after the first screening round (34.78 and 19.45%, respectively, P = 0.0169). Results were all the more significant in a subset analysis on early T stage colon subgroups (In vs Out) both for LN harvesting (P < 0.0001) and nodal positivity (P < 0.0001).
CONCLUSION: xSignificant differences between RC and DHs were found, particularly for early-stage CRC patients. LN harvesting should be considered as a surrogate marker of quality assurance for at least screening hospitals for "minimum best" standard of care. This should lead to set up a third level in any CCSP.

Entities:  

Keywords:  Colorectal cancer screening; Lymph nodal harvesting; Multidisciplinary team; Quality assurance; Referral centre; Third level surgery

Mesh:

Year:  2015        PMID: 26715436     DOI: 10.1007/s00384-015-2472-7

Source DB:  PubMed          Journal:  Int J Colorectal Dis        ISSN: 0179-1958            Impact factor:   2.571


  27 in total

1.  Management of the malignant colorectal polyp: ACPGBI position statement.

Authors:  J G Williams; R D Pullan; J Hill; P G Horgan; E Salmo; G N Buchanan; S Rasheed; S G McGee; N Haboubi
Journal:  Colorectal Dis       Date:  2013-08       Impact factor: 3.788

2.  Lymph node evaluation as a colon cancer quality measure: a national hospital report card.

Authors:  Karl Y Bilimoria; David J Bentrem; Andrew K Stewart; Mark S Talamonti; David P Winchester; Thomas R Russell; Clifford Y Ko
Journal:  J Natl Cancer Inst       Date:  2008-09-09       Impact factor: 13.506

3.  A national study on lymph node retrieval in resectional surgery for colorectal cancer.

Authors:  Paris P Tekkis; Jason J Smith; Alexander G Heriot; Ara W Darzi; Michael R Thompson; Jeffrey D Stamatakis
Journal:  Dis Colon Rectum       Date:  2006-11       Impact factor: 4.585

4.  Evaluating the validity of quality indicators for colorectal cancer care.

Authors:  Gea A Gooiker; Nikki E Kolfschoten; Esther Bastiaannet; Cornelis J H van de Velde; Eric H Eddes; Erwin van der Harst; Theo Wiggers; Frits R Rosendaal; Rob A E M Tollenaar; Michel W J M Wouters
Journal:  J Surg Oncol       Date:  2013-09-20       Impact factor: 3.454

5.  Volume of surgical activity and lymph node evaluation for patients with colorectal cancer in France.

Authors:  Olivier Dejardin; Edouard Ruault; Valérie Jooste; Carole Pornet; Véronique Bouvier; Anne-Marie Bouvier; Guy Launoy
Journal:  Dig Liver Dis       Date:  2011-11-25       Impact factor: 4.088

6.  Management and short-term outcome of malignant colorectal polyps in the north of England(1).

Authors:  M D Gill; M D Rutter; S J Holtham
Journal:  Colorectal Dis       Date:  2013-02       Impact factor: 3.788

7.  Individual surgeon, pathologist, and other factors affecting lymph node harvest in stage II colon carcinoma. is a minimum of 12 examined lymph nodes sufficient?

Authors:  Luca Stocchi; Victor W Fazio; Ian Lavery; Jeff Hammel
Journal:  Ann Surg Oncol       Date:  2010-09-14       Impact factor: 5.344

Review 8.  Colorectal cancer and lymph nodes: the obsession with the number 12.

Authors:  Giovanni Li Destri; Isidoro Di Carlo; Roberto Scilletta; Beniamino Scilletta; Stefano Puleo
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

Review 9.  Experts reviews of the multidisciplinary consensus conference colon and rectal cancer 2012: science, opinions and experiences from the experts of surgery.

Authors:  C J H van de Velde; P G Boelens; P J Tanis; E Espin; P Mroczkowski; P Naredi; L Pahlman; H Ortiz; H J Rutten; A J Breugom; J J Smith; A Wibe; T Wiggers; V Valentini
Journal:  Eur J Surg Oncol       Date:  2013-11-08       Impact factor: 4.424

10.  EURECCA colorectal: multidisciplinary management: European consensus conference colon & rectum.

Authors:  Cornelis J H van de Velde; Petra G Boelens; Josep M Borras; Jan-Willem Coebergh; Andres Cervantes; Lennart Blomqvist; Regina G H Beets-Tan; Colette B M van den Broek; Gina Brown; Eric Van Cutsem; Eloy Espin; Karin Haustermans; Bengt Glimelius; Lene H Iversen; J Han van Krieken; Corrie A M Marijnen; Geoffrey Henning; Jola Gore-Booth; Elisa Meldolesi; Pawel Mroczkowski; Iris Nagtegaal; Peter Naredi; Hector Ortiz; Lars Påhlman; Philip Quirke; Claus Rödel; Arnaud Roth; Harm Rutten; Hans J Schmoll; Jason J Smith; Pieter J Tanis; Claire Taylor; Arne Wibe; Theo Wiggers; Maria A Gambacorta; Cynthia Aristei; Vincenzo Valentini
Journal:  Eur J Cancer       Date:  2013-10-31       Impact factor: 9.162

View more
  2 in total

1.  T1 colon cancer in the era of screening: risk factors and treatment.

Authors:  F Bianco; S De Franciscis; A Belli; A Falato; R Fusco; D F Altomare; A Amato; C R Asteria; A Avallone; G A Binda; L Boccia; P Buzzo; M Carvello; C Coco; P Delrio; P De Nardi; M Di Lena; A Failla; F La Torre; M La Torre; M Lemma; P Luffarelli; G Manca; I Maretto; F Marino; A Muratore; A Pascariello; S Pucciarelli; D Rega; V Ripetti; G Rizzo; A Serventi; A Spinelli; F Tatangelo; E D L Urso; G M Romano
Journal:  Tech Coloproctol       Date:  2017-02-13       Impact factor: 3.781

2.  The prognostic value of lymph node yield in the earliest stage of colorectal cancer: a multicenter cohort study.

Authors:  Yara Backes; Sjoerd G Elias; Bibie S Bhoelan; John N Groen; Jeroen van Bergeijk; Tom C J Seerden; Hendrikus J M Pullens; Bernhard W M Spanier; Joost M J Geesing; Koen Kessels; Marjon Kerkhof; Peter D Siersema; Wouter H de Vos Tot Nederveen Cappel; Niels van Lelyveld; Frank H J Wolfhagen; Frank Ter Borg; G Johan A Offerhaus; Miangela M Lacle; Leon M G Moons
Journal:  BMC Med       Date:  2017-07-14       Impact factor: 8.775

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.